In terms of treatment, tissue plasminogen activator (t-PA) is the only thrombolytic drug approved by the Food and Drug Administration for the therapy of ischemic stroke, which dissolves thrombus by activating a proteolytic enzyme [4]. This evidence concerns the gene PLAT and ischemic stroke.